Bringing in pleasant news for Petrobras (PBR - Free Report) , the Brazilian Supreme Court recently lifted the suspension order on the company that put a pause on its asset divestiture program. The court’s ruling brought relief to the state-held energy giant as the suspension order had posed a severe threat to the company’s aim of mitigating huge debt.
In May, the court had suspended the sale of the TAG pipeline unit, eight refineries and the Araucaria Nitrogenous fertilizer business, putting Petrobras’ divestment plans in jeopardy. Supreme Court Justice Edson Fachin halted the $8.6-billion sale of the TAG unit to Engie SA-led consortium, arguing that the divestments of subsidiaries by state-owned companies needed congressional approval. Markedly, the TAG sale is supposed to be the largest-ever single asset sale for the Brazilian energy giant, which has been making serious efforts to trim its huge debt burden.
Marking a major victory for the Bolsonaro government and Petrobras, the court recently ruled that state-held companies do not require congressional approval to jettison their subsidiaries. The ruling is a boon for other state-owned firms like Eletrobras, which is also contemplating to offload some of its assets.
For Petrobras, the divestment plans are is in sync with the aim of cutting debt levels. Notably, while the company’s net debt of $100 billion peaked in 2015, concentrated efforts to lower leverage, boost liquidity through operational efficiency and divestment of non-core assets have helped Petrobras in deleveraging to a considerable extent. In 2018, its net debt declined to $69.4 billion from $84.9 billion a year ago and $96.4 billion in 2016. The finalization of the sale of TAG assets and other divestments are likely to give a considerable boost to the company’s financials.
As we know, Petrobras revved up its five-year plan in March, and now intends to offload $26.9 billion through 2023, streamline portfolio and sharpen focus on other profitable segments for achieving top-tier results. The firm is entering into various strategic partnerships with foreign oil giants to drive exploration momentum. In this regard, the Zacks Rank #3 (Hold) company inked deals with major players like TOTAL S.A. , Royal Dutch Shell plc and Equinor ASA (EQNR - Free Report) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Bringing in pleasant news for Petrobras (PBR - Free Report) , the Brazilian Supreme Court recently lifted the suspension order on the company that put a pause on its asset divestiture program. The court’s ruling brought relief to the state-held energy giant as the suspension order had posed a severe threat to the company’s aim of mitigating huge debt.
In May, the court had suspended the sale of the TAG pipeline unit, eight refineries and the Araucaria Nitrogenous fertilizer business, putting Petrobras’ divestment plans in jeopardy. Supreme Court Justice Edson Fachin halted the $8.6-billion sale of the TAG unit to Engie SA-led consortium, arguing that the divestments of subsidiaries by state-owned companies needed congressional approval. Markedly, the TAG sale is supposed to be the largest-ever single asset sale for the Brazilian energy giant, which has been making serious efforts to trim its huge debt burden.
Marking a major victory for the Bolsonaro government and Petrobras, the court recently ruled that state-held companies do not require congressional approval to jettison their subsidiaries. The ruling is a boon for other state-owned firms like Eletrobras, which is also contemplating to offload some of its assets.
For Petrobras, the divestment plans are is in sync with the aim of cutting debt levels. Notably, while the company’s net debt of $100 billion peaked in 2015, concentrated efforts to lower leverage, boost liquidity through operational efficiency and divestment of non-core assets have helped Petrobras in deleveraging to a considerable extent. In 2018, its net debt declined to $69.4 billion from $84.9 billion a year ago and $96.4 billion in 2016. The finalization of the sale of TAG assets and other divestments are likely to give a considerable boost to the company’s financials.
As we know, Petrobras revved up its five-year plan in March, and now intends to offload $26.9 billion through 2023, streamline portfolio and sharpen focus on other profitable segments for achieving top-tier results. The firm is entering into various strategic partnerships with foreign oil giants to drive exploration momentum. In this regard, the Zacks Rank #3 (Hold) company inked deals with major players like TOTAL S.A. , Royal Dutch Shell plc and Equinor ASA (EQNR - Free Report) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PBR - FREE
Get the latest research report on EQNR - FREE